National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 65707-65708 [2023-20655]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 184 / Monday, September 25, 2023 / Notices
ddrumheller on DSK120RN23PROD with NOTICES1
• 10 U.S.C. 1034, made applicable to
the Public Health Service
Commissioned Corps through section
1129 of the Food and Drug
Administration Safety and Innovation
Act, Public Law 112–144, and
implemented by Commissioned Corps
Directive (CCD) 121.06: https://
dcp.psc.gov/ccmis/ccis/documents/
CCD121_06.pdf
scientific integrity policy. The
requirements of this policy are derived
from the 2022 National Science and
Technology Council (NSTC) Report of
the Scientific Integrity Fast Track
Action Committee, Protecting the
Integrity of Government Science at
https://www.whitehouse.gov/wpcontent/uploads/2022/01/01-22Protecting_the_Integrity_of_
Government_Science.pdf, and align
Other Related Policies
with the principles set forth in the
• NIH Data Management and Sharing
NSTC guidance document A Framework
Policy: https://sharing.nih.gov/datafor Federal Scientific Integrity Policy
management-and-sharing-policy
and Practice at https://
• Public Law 115–435—Foundations for www.whitehouse.gov/wp-content/
Evidence-Based Policymaking Act
uploads/2023/01/01-2023-Framework(‘‘Evidence Act’’): https://
for-Federal-Scientific-Integrity-Policywww.congress.gov/115/plaws/
and-Practice.pdf.
publ435/PLAW-115publ435.pdf
This policy is established in
• Public Law 107–174—Notification
accordance with:
and Federal Employee
1. Public Law 111–358—The America
Antidiscrimination and Retaliation
COMPETES Reauthorization Act of
Act (‘‘No FEAR Act’’): https://
2010, section 103, as amended
uscode.house.gov/statutes/pl/107/
2. Public Law 115–435—The
174.pdf
Foundations for Evidence-based
• U.S. Government Policy for
Policymaking Act of 2018
Institutional Oversight of Life
3. Public Law 106–554—The
Sciences Dual Use Research of
Information Quality Act of 2000
Concern: https://www.phe.gov/s3/
4. 67 FR 8451—OMB Guidelines for
dualuse/documents/durc-policy.pdf
Ensuring and Maximizing the
• U.S. Government Policy for Oversight
Quality, Objectivity, Utility, and
of Life Sciences Dual Use Research of
Integrity of Information
Concern: https://www.phe.gov/s3/
Disseminated by Federal Agencies
dualuse/Documents/us-policy-durc5.
70
FR 2664—OMB Final Information
032812.pdf
Quality Bulletin for Peer Review
• Public Law 92–463—The Federal
6. 65 FR 76260–76264—Federal Policy
Advisory Committee Act: https://
on Research Misconduct
uscode.house.gov/statutes/pl/92/
7. Public Law 101–12—The
463.pdf
Whistleblower Protection Act
• Public Law 104–13—Paperwork
(WPA) of 1989, as amended
Reduction Act: https://
www.congress.gov/104/plaws/publ13/ 8. 41 U.S.C. 4712—The National
Defense Authorization Act,
PLAW-104publ13.pdf
Enhancement of contractor
Authorities
protection from reprisal for
Pursuant to the 2021 Presidential
disclosure of certain information
Memorandum on Restoring Trust in
9. 5 U.S.C. 13103 et seq.—The Ethics in
Government Through Scientific
Government Act of 1978, as
Integrity and Evidence-Based
amended, and 5 CFR parts 2634 and
Policymaking at https://
2635, Executive Branch Financial
www.whitehouse.gov/briefing-room/
Disclosure, Qualified Trusts, and
presidential-actions/2021/01/27/
Certificates of Divestiture and
memorandum-on-restoring-trust-inStandards of Ethical Conduct for
government-through-scientific-integrityEmployees of the Executive Branch.
and-evidence-based-policymaking/, and 10. 18 U.S.C. 201–209—Statutes
consistent with the 2009 Presidential
regarding Bribery, Graft and
Memorandum on Scientific Integrity at
Conflicts of Interest
https://obamawhitehouse.archives.gov/
11. 5 CFR parts 5501 and 5502—
the-press-office/memorandum-headsSupplemental Standards of Ethical
executive-departments-and-agencies-3Conduct for Employees of the
9-09 and the 2010 Memorandum from
Department of Health and Human
the White House Office of Science and
Services
Technology Policy on Scientific
12. 5 U.S.C. Ch. 10—The Federal
Integrity at https://
Advisory Committee Act of 1972
obamawhitehouse.archives.gov/sites/
13. 45 CFR part 73, Standards of
default/files/microsites/ostp/scientificConduct
14. 5 CFR part 735, Employee
integrity-memo-12172010.pdf, all
Responsibilities and Conduct
Federal agencies must establish a
VerDate Sep<11>2014
20:11 Sep 22, 2023
Jkt 259001
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
65707
15. HHS Protection of Human Subjects
Regulation (45 CFR part 46).
16. PPD 19—Protecting Whistleblowers
with Access to Classified
Information, 2012
17. M–20–12—OMB Phase 4
Implementation of the Foundations
for Evidence-Based Policymaking
Act of 2018: Program Evaluation
Standards and Practices
18. 42 CFR part 93—Public Health
Service Policies on Research
Misconduct
19. 10 U.S.C. 1034, made applicable to
the Public Health Service
Commissioned Corps through
section 1129 of the Food and Drug
Administration Safety and
Innovation Act, Public Law 112–
144, and implemented by
Commissioned Corps Directive
(CCD) 121.06
20. Health Extenders, Improving Access
to Medicare, Medicaid, and CHIP,
and Strengthening Public Health
Act of 2022, Public Law 117–328,
Division FF, title II, section 2321
(Jan 3, 2023)
21. Chips and Science Act, Public Law
117–167, title VI, subtitle D, section
10631 (Aug 9, 2022)
Dated: September 19, 2023.
Tara A. Schwetz,
Acting Principal Deputy Director, National
Institutes of Health.
[FR Doc. 2023–20733 Filed 9–22–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Microbiology,
Infectious Diseases and AIDS Initial Review
Group; Microbiology and Infectious Diseases
E:\FR\FM\25SEN1.SGM
25SEN1
65708
Federal Register / Vol. 88, No. 184 / Monday, September 25, 2023 / Notices
Research Study Section Microbiology and
Infectious Diseases Research Study Section.
Date: October 24–25, 2023.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bahia Resort Hotel, 998 West
Mission Bay Drive, Ventana Room, San
Diego, CA 92109.
Contact Person: Eleazar Cohen, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institute of Health, 5601
Fishers Lane, RM 3G62, Bethesda, MD 20892,
(240) 669–5081, ecohen@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: September 19, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–20655 Filed 9–22–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
Accreditation and Approval of Saybolt
LP (Guayanilla, PR) as a Commercial
Gauger and Laboratory
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: Notice of accreditation and
approval of Saybolt LP (Guayanilla, PR),
as a commercial gauger and laboratory.
AGENCY:
Notice is hereby given,
pursuant to CBP regulations, that
Saybolt LP (Guayanilla, PR) has been
approved to gauge petroleum and
certain petroleum products and
accredited to test petroleum and certain
petroleum products for customs
purposes for the next four years as of
November 16, 2020.
DATES: Saybolt LP (Guayanilla, PR) was
approved and accredited as a
commercial gauger and laboratory as of
November 16, 2020. The next inspection
date will be scheduled for November
2024.
SUMMARY:
Mr.
Robert P. Munivez, Laboratories and
Scientific Services, U.S. Customs and
Border Protection, 4150 Interwood
FOR FURTHER INFORMATION CONTACT:
ddrumheller on DSK120RN23PROD with NOTICES1
CBPL No.
ASTM
27–01 ..........................................
D287
27–02 ..........................................
D1298
27–08 ..........................................
27–11 ..........................................
D86
D445
27–13 ..........................................
D4294
27–48 ..........................................
D4052
N/A ..............................................
D1657
1 As a result of the SARS–CoV–2 (COVID–19)
pandemic, Laboratories and Scientific Services
implemented a one-time quadrennial timeframe for
reoccurring audits originally scheduled to take
place in 2020, 2021, and 2022. This postponed the
scheduled deadline for audits and the payment of
reaccreditation or reapproval fees by one year, after
which audits will return to a triennial schedule. See
19 U.S.C. 1499; Presidential Proclamation 9994, 85
FR 15337 (March 13, 2020); Executive Order 13924,
Jkt 259001
3 ...................
7 ...................
8 ...................
12 .................
17 .................
Title
Tank Gauging.
Temperature Determination.
Sampling.
Calculations.
Marine Measurement.
Saybolt LP (Guayanilla, PR) is
accredited for the following laboratory
analysis procedures and methods for
petroleum and certain petroleum
products set forth by the U.S. Customs
and Border Protection Laboratory
Methods (CBPL) and American Society
for Testing and Materials (ASTM):
Standard Test Method for API Gravity of Crude Petroleum and Petroleum Products (Hydrometer
Method).
Standard Test Method for Density, Relative Density, or API Gravity of Crude Petroleum and Liquid Petroleum Products by Hydrometer Method.
Standard Test Method for Distillation of Petroleum Products at Atmospheric Pressure.
Standard Test Method for Kinematic Viscosity of Transparent and Opaque Liquids (and Calculation of Dynamic Viscosity).
Standard Test Method for Sulfur in Petroleum and Petroleum Products by Energy-Dispersive Xray Fluorescence Spectrometry.
Standard Test Method for Density, Relative Density, and API Gravity of Liquids by Digital Density Meter.
Standard Test Method for Density or Relative Density of Light Hydrocarbons by Pressure Hydrometer.
to the U.S. Customs and Border
Protection by calling (202) 344–1060.
The inquiry may also be sent to
CBPGaugersLabs@cbp.dhs.gov. Please
reference the website listed below for a
complete listing of CBP approved
gaugers and accredited laboratories.
20:11 Sep 22, 2023
API Chapters
Title
Anyone wishing to employ this entity
to conduct laboratory analyses and
gauger services should request and
receive written assurances from the
entity that it is accredited or approved
by the U.S. Customs and Border
Protection to conduct the specific test or
gauger service requested. Alternatively,
inquiries regarding the specific test or
gauger service this entity is accredited
or approved to perform may be directed
VerDate Sep<11>2014
South Parkway, Houston, TX 77032, tel.
281–560–2937.
SUPPLEMENTARY INFORMATION: Notice is
hereby given pursuant to 19 CFR 151.12
and 19 CFR 151.13, that Saybolt LP,
Road 127, Km 11.7, Guayanilla, PR
00656, has been approved to gauge
petroleum and certain petroleum
products and accredited to test
petroleum and certain petroleum
products for customs purposes, in
accordance with the provisions of 19
CFR 151.12 and 19 CFR 151.13 as of
November 16, 2020.1
Saybolt LP (Guayanilla, PR) is
approved for the following gauging
procedures for petroleum and certain
petroleum products from the American
Petroleum Institute (API):
https://www.cbp.gov/about/labsscientific/commercial-gaugers-andlaboratories.
James D. Sweet,
Laboratory Director, Houston, Laboratories
and Scientific Services.
[FR Doc. 2023–20688 Filed 9–22–23; 8:45 am]
BILLING CODE 9111–14–P
PO 00000
Frm 00059
Fmt 4703
Sfmt 9990
85 FR 31353 (May 19, 2020); and U.S. Customs &
Border Protection, COVID–19 Laboratory and
Gauger Postponement Letter (May 26, 2021),
https://www.cbp.gov/document/guidance/covid-19gauger-postponement-letter.
E:\FR\FM\25SEN1.SGM
25SEN1
]]>Agencies
[Federal Register Volume 88, Number 184 (Monday, September 25, 2023)]
[Notices]
[Pages 65707-65708]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-20655]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Microbiology, Infectious Diseases and AIDS
Initial Review Group; Microbiology and Infectious Diseases
[[Page 65708]]
Research Study Section Microbiology and Infectious Diseases Research
Study Section.
Date: October 24-25, 2023.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bahia Resort Hotel, 998 West Mission Bay Drive, Ventana
Room, San Diego, CA 92109.
Contact Person: Eleazar Cohen, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities,
National Institute of Allergy and Infectious Diseases, National
Institute of Health, 5601 Fishers Lane, RM 3G62, Bethesda, MD 20892,
(240) 669-5081, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: September 19, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-20655 Filed 9-22-23; 8:45 am]
BILLING CODE 4140-01-P
